SCHEMBL29676733

SCHEMBL29676733

Clc1ccc2c(c1)CCNCC2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 11/20 1.00
HTR2A P28223 10/20 1.00
HTR2B P41595 9/20 1.00
PNMT P11086 1/20 0.77
ADRB1 P08588 1/20 0.55
HTR1A P08908 1/20 0.55
ADRA2A P08913 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
CNR1 P21554 1/20 0.55
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
HRH1 P35367 1/20 0.55
KCNH2 Q12809 1/20 0.55
DRD2 P14416 1/20 0.52
DRD1 P21728 1/20 0.52
ASIC3 Q9UHC3 1/20 0.50
MLNR O43193 1/20 0.49
F7 P08709 1/20 0.48
PARP1 P09874 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881688 1.00 HTR2C (1.00) HTR2CHTR2AHTR2BPNMTADRB1
Hydrochloric Acid SCHEMBL5767968 0.98 HTR2C (0.96) HTR2CHTR2AHTR2BPNMTADRB1
SCHEMBL532012 0.87 PNMT (0.85) HTR2CHTR2AHTR2BPNMTADRB1
SCHEMBL29587836 0.87 PNMT (1.00) HTR2CHTR2AHTR2BPNMTADRA2A
SCHEMBL329775 0.87 PNMT (1.00) HTR2CHTR2AHTR2BPNMTADRA2A
Hydrochloric Acid SCHEMBL1124954 0.85 PNMT (0.96) HTR2CHTR2AHTR2BPNMTADRA2A
Hydrochloric Acid SCHEMBL947776 0.85 PNMT (0.81) HTR2CHTR2AHTR2BPNMTADRB1
SCHEMBL15962624 0.83
Ammonia Solution, Strong SCHEMBL10465265 0.80 HTR2A (0.67) HTR2CHTR2AHTR2BPNMTF7
SCHEMBL31317921 0.79 HTR2C (0.65) HTR2CHTR2AHTR2BPNMTADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114948963-B Benzolactam compounds as protein kinase inhibitors 大冢制药株式会社 2025-05-27 CN disclosed
CN-113754635-B Condensed ring compound and preparation method and application thereof 成都康弘药业集团股份有限公司 2024-06-21 CN disclosed
EP-4291177-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY Recovery Therapeutics, Inc. (US) 2023-12-20 EP disclosed
CN-117157069-A Compounds, compositions and methods for modulating FGF activity 康复治疗公司 2023-12-01 CN disclosed
CN-114948963-A Protein kinase inhibitor benzolactam compounds 大冢制药株式会社 2022-08-30 CN disclosed
WO-2022174083-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING FGF ACTIVITY RECOVERY THERAPEUTICS, INC. (US) 2022-08-18 WO disclosed
CN-108617166-B Protein kinase inhibitor benzolactam compounds 大冢制药株式会社 2022-05-17 CN disclosed